Pravachol Exclusivity: Teva Wins By Winning– FDA Wins By Losing?

A recent D.C. federal appeals court decision affirming Teva's exclusivity period for Pravachol generics opens the door for new standard-setting by FDA on what conditions trigger the start of 180-day exclusivity